SCHEMBL21237720

SCHEMBL21237720

NC(C(=O)Nc1nccs1)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.67
RAB9A P51151 3/20 0.67
LMNA P02545 3/20 0.67
TSHR P16473 1/20 0.67
ACP1 P24666 1/20 0.65
CYP1A2 P05177 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
CYP3A4 P08684 1/20 0.62
CYP2D6 P10635 1/20 0.62
CYP2C9 P11712 1/20 0.62
CYP2C19 P33261 1/20 0.62
ALDH1A1 P00352 1/20 0.61
NR3C1 P04150 1/20 0.58
AURKA O14965 1/20 0.56
PIM1 P11309 1/20 0.56
CDK2 P24941 1/20 0.56
GSK3B P49841 1/20 0.56
GLS O94925 2/20 0.54
HSPA5 P11021 2/20 0.54
HSPA9 P38646 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30765209 0.99 NPC1 (0.65) NPC1RAB9ALMNATSHRACP1
Hydrochloric Acid SCHEMBL20576283 0.99 NPC1 (0.65) NPC1RAB9ALMNATSHRACP1
SCHEMBL4238173 0.84 NPC1 (0.65) NPC1RAB9ALMNATSHRACP1
Hydrochloric Acid SCHEMBL20577157 0.83 NPC1 (0.53) NPC1RAB9ALMNATSHRACP1
Hydrochloric Acid SCHEMBL30765097 0.83 NPC1 (0.53) NPC1RAB9ALMNATSHRACP1
SCHEMBL20887927 0.82 LMNA (0.75) NPC1RAB9ALMNATSHRACP1
SCHEMBL28706247 0.81 NPC1 (0.61) NPC1RAB9ALMNATSHRACP1
SCHEMBL20577306 0.80 TSHR (0.64) NPC1RAB9ALMNATSHRACP1
SCHEMBL18939372 0.79 CYP1A2 (0.81) NPC1RAB9ALMNATSHRACP1
SCHEMBL18289897 0.79 ACP1 (1.00) NPC1RAB9ALMNATSHRACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019149922-A1 COMPOUNDS WHICH CAUSE DEGRADATION OF EGFR, FOR USE AGAINST CANCER F. HOFFMANN-LA ROCHE AG (CH) 2019-08-08 WO disclosed